Frozen copy retrieved 2026-08-20T19:30:00Z for audit 2026-08-20T21-09-12Z. Original URL: https://www.timesofisrael.com/moderna-vaccine-trial-reveals-success-in-curbing-melanoma-recurrence/. The Stochastic Parrot does not host or redistribute; this snapshot exists solely so that quoted spans remain verifiable if the original page changes. Character offsets below index into this plain text; highlighted spans are the quotes cited in the audit.

'Breakthrough' Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

The Times of Israel (Reuters wire reprint — REDUNDANT with KSL/Investing.com Reuters pieces; context only, do not list as distinct outlet) · back to the audit

Reuters wire (bylined Michael Erman and Julie Steenhuysen) reprinted by Times of Israel. Redundant with the KSL.com and Investing.com Reuters captures; NOT to be listed as a distinct outlet in the piece. Carries the same "shares surging as much as 160%" lead and the same verbatim spans as the Reuters KSL capture, plus: lead "Reuters - Moderna said Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent the drugmaker's shares surging as much as 160%."